Immunotherapy in Head & Neck Cancer

Immunotherapy has become a significant treatment approach for head and neck cancer, particularly for recurrent or metastatic cases. It works by harnessing the body's own immune system to target and destroy cancer cells. Key drugs like pembrolizumab and nivolumab, which are immune checkpoint inhibitors, have been approved for certain types of head and neck cancer.